1. Cell delivery devices for cancer immunotherapy.
- Author
-
Wen, Ping, Wu, Wei, Wang, Feifan, Zheng, Hanqi, Liao, Ziyan, Shi, Jiaqi, Zhu, Chaojie, Zhao, Peng, Cheng, Hao, Li, Hongjun, and Gu, Zhen
- Subjects
- *
TUMOR treatment , *IMMUNOTHERAPY , *HEMATOLOGIC malignancies , *INTRAVENOUS therapy , *CANCER treatment - Abstract
Adoptive cell therapy (ACT) that leverages allogeneic or autologous immune cells holds vast promise in targeted cancer therapy. Despite the tremendous success of ACT in treating hematopoietic malignancies, its efficacy is limited in eradicating solid tumors via intravenous infusion of immune cells. With the extending technology of cancer immunotherapy, novel delivery strategies have been explored to improve the therapeutic potency of adoptively transferred cells for solid tumor treatment by innovating the administration route, maintaining the cell viability, and normalizing the tumor microenvironment. In this review, a variety of devices for cell delivery are summarized. Perspectives and challenges of cell delivery devices for cancer immunotherapy are also discussed. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF